Datasets:
SKT27182
/
NER_processed_data

Dataset card Data Studio Files
xet
 Community
1
id
stringlengths
11
11
tags
stringlengths
10
777
text
stringlengths
2
1.5k
dataset_num
int64
1
3
tokens
list
ner_tags
list
NCT02402647
1:18:chronic_disease
Hoarding Disorder diagnosis outlined by the Diagnostic and Statistical Manual of Mental Disorders
2
[ "Hoarding", "Disorder", "diagnosis", "outlined", "by", "the", "Diagnostic", "and", "Statistical", "Manual", "of", "Mental", "Disorders" ]
[ 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02485639
38:42:allergy_name,38:41:allergy_name,51:66:allergy_name,107:120:allergy_name
known hypersensitivity or allergy to eggs, egg or chicken protein, report of allergy to components of the study vaccine or other components of the study vaccine
2
[ "known", "hypersensitivity", "or", "allergy", "to", "eggs", ",", "egg", "or", "chicken", "protein", ",", "report", "of", "allergy", "to", "components", "of", "the", "study", "vaccine", "or", "other", "components", "of", "the", "study", "vaccine" ]
[ 0, 0, 0, 0, 0, 4, 0, 4, 0, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 4, 4, 0, 0, 0, 0, 0, 0, 0 ]
NCT01600131
75:81:chronic_disease,,
provide the majority of care for a Veteran who has a primary diagnosis of stroke (ICD9 codes for stroke: 430-438)
2
[ "provide", "the", "majority", "of", "care", "for", "a", "Veteran", "who", "has", "a", "primary", "diagnosis", "of", "stroke", "(", "ICD9", "codes", "for", "stroke", ":", "430-438", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02171104
1:33:chronic_disease
MPS VI (Maroteaux-Lamy syndrome)
2
[ "MPS", "VI", "(", "Maroteaux-Lamy", "syndrome", ")" ]
[ 2, 2, 2, 2, 0, 0 ]
NCT02907983
10:25:treatment
for whom hormone therapy is contraindicated
2
[ "for", "whom", "hormone", "therapy", "is", "contraindicated" ]
[ 0, 0, 1, 1, 0, 0 ]
NCT03058029
1:18:treatment,
Blood transfusion within three (3) months prior to Screening Visit
2
[ "Blood", "transfusion", "within", "three", "(", "3", ")", "months", "prior", "to", "Screening", "Visit" ]
[ 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02562716
10:20:cancer,62:67:cancer,72:85:cancer,87:98:cancer,92:98:cancer,100:123:cancer,125:166:cancer,227:236:treatment,
No prior malignancy is allowed except for adequately treated basal (or squamous cell) skin cancer, in situ cervical cancer, in situ breast (ductal or lobular) cancer, or other cancer for which the patient has been disease and treatment-free for two years
2
[ "No", "prior", "malignancy", "is", "allowed", "except", "for", "adequately", "treated", "basal", "(", "or", "squamous", "cell", ")", "skin", "cancer", ",", "in", "situ", "cervical", "cancer", ",", "in", "situ", "breast", "(", "ductal", "or", "lobular", ")"...
[ 0, 0, 3, 0, 0, 0, 0, 0, 0, 3, 0, 0, 3, 3, 0, 3, 3, 0, 3, 3, 3, 3, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0 ]
NCT01782599
14:25:chronic_disease
a history of head trauma
2
[ "a", "history", "of", "head", "trauma" ]
[ 0, 0, 0, 2, 2 ]
NCT02346253
23:45:treatment
Past history of other investigational agents
2
[ "Past", "history", "of", "other", "investigational", "agents" ]
[ 0, 0, 0, 0, 1, 1 ]
NCT01990209
15:46:cancer
Patients with metastases limited to the bones
2
[ "Patients", "with", "metastases", "limited", "to", "the", "bones" ]
[ 0, 0, 3, 3, 3, 3, 3 ]
NCT01433315
61:75:treatment,77:87:treatment,89:101:treatment,103:116:treatment,118:128:treatment
On no prescription medications other than second generation antihistamines (Cetirizine, Fexofenadine, Desloratadine, Loratadine, etc), oral contraceptive pills, or intrauterine devices
2
[ "On", "no", "prescription", "medications", "other", "than", "second", "generation", "antihistamines", "(", "Cetirizine", ",", "Fexofenadine", ",", "Desloratadine", ",", "Loratadine", ",", "etc", ")", ",", "oral", "contraceptive", "pills", ",", "or", "intrauterine"...
[ 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02206945
1:22:chronic_disease
severe claustrophobia
2
[ "severe", "claustrophobia" ]
[ 2, 2 ]
NCT01515527
,,58:75:treatment
Patients aged < 60 years who are unsuitable for standard induction therapy may be eligible after discussion with PI
2
[ "Patients", "aged", "<", "60", "years", "who", "are", "unsuitable", "for", "standard", "induction", "therapy", "may", "be", "eligible", "after", "discussion", "with", "PI" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT02554903
1:35:treatment,43:51:treatment,53:65:treatment,70:82:treatment,,126:135:treatment
Treatment with inhaled prostanoids (e.g., iloprost, epoprostenol) or nitric oxide within 24 h prior to Baseline RHC or study treatment initiation
2
[ "Treatment", "with", "inhaled", "prostanoids", "(", "e.g.", ",", "iloprost", ",", "epoprostenol", ")", "or", "nitric", "oxide", "within", "24", "h", "prior", "to", "Baseline", "RHC", "or", "study", "treatment", "initiation" ]
[ 1, 1, 1, 1, 0, 0, 0, 1, 0, 1, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0 ]
NCT02710331
1:17:chronic_disease
Hearing deficits
2
[ "Hearing", "deficits" ]
[ 2, 2 ]
NCT02402660
26:41:chronic_disease,211:227:treatment,,254:288:chronic_disease
Has active or historical ocular disorder in the primary study eye that, in the opinion of the investigator, may confound assessment of the retina morphologically or functionally (this could include for example cataract surgery within the past 6 months, choroidal neovascularization (CNV)
2
[ "Has", "active", "or", "historical", "ocular", "disorder", "in", "the", "primary", "study", "eye", "that", ",", "in", "the", "opinion", "of", "the", "investigator", ",", "may", "confound", "assessment", "of", "the", "retina", "morphologically", "or", "function...
[ 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 2, 2, 2, 0, 0 ]
NCT02576431
30:39:chronic_disease,41:46:chronic_disease,51:67:chronic_disease,78:100:chronic_disease,111:127:chronic_disease
Active uncontrolled systemic bacterial, viral, or fungal infection, unstable cardiovascular disease, or other systemic disease that would limit compliance with study procedures
2
[ "Active", "uncontrolled", "systemic", "bacterial", ",", "viral", ",", "or", "fungal", "infection", ",", "unstable", "cardiovascular", "disease", ",", "or", "other", "systemic", "disease", "that", "would", "limit", "compliance", "with", "study", "procedures" ]
[ 0, 0, 2, 2, 0, 2, 0, 0, 2, 2, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02516670
25:59:chronic_disease,55:58:chronic_disease,82:93:chronic_disease,98:119:chronic_disease
Have a known history of human immunodeficiency virus (HIV) (HIV 1/2 antibodies), hepatitis B, or hepatitis C infection
2
[ "Have", "a", "known", "history", "of", "human", "immunodeficiency", "virus", "(", "HIV", ")", "(", "HIV", "1/2", "antibodies", ")", ",", "hepatitis", "B", ",", "or", "hepatitis", "C", "infection" ]
[ 0, 0, 0, 0, 0, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 2, 2, 2, 0, 0, 0, 0 ]
NCT02824276
15:34:treatment
candidate for oral opioid therapy as assessed at the BWH Pain Management Center
2
[ "candidate", "for", "oral", "opioid", "therapy", "as", "assessed", "at", "the", "BWH", "Pain", "Management", "Center" ]
[ 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02707471
,31:34:chronic_disease
within 12 months of beginning AET
2
[ "within", "12", "months", "of", "beginning", "AET" ]
[ 0, 0, 0, 0, 0, 2 ]
NCT02648282
42:45:chronic_disease,47:58:chronic_disease,63:74:chronic_disease
who have known history of infection with HIV, hepatitis B, or hepatitis C
2
[ "who", "have", "known", "history", "of", "infection", "with", "HIV", ",", "hepatitis", "B", ",", "or", "hepatitis", "C" ]
[ 0, 0, 0, 0, 0, 0, 0, 2, 0, 2, 2, 0, 0, 0, 0 ]
NCT02332668
1:20:treatment,30:39:treatment,41:48:treatment,53:99:treatment,104:111:chronic_disease,115:138:chronic_disease
replacement therapy (such as thyroxine, insulin, or physiologic corticosteroid replacement therapy for adrenal or pituitary insufficiency) is acceptable
2
[ "replacement", "therapy", "(", "such", "as", "thyroxine", ",", "insulin", ",", "or", "physiologic", "corticosteroid", "replacement", "therapy", "for", "adrenal", "or", "pituitary", "insufficiency", ")", "is", "acceptable" ]
[ 1, 1, 0, 0, 0, 1, 0, 1, 0, 0, 1, 1, 1, 1, 0, 2, 0, 2, 2, 0, 0, 0 ]
NCT02374333
16:36:treatment
relapsed after prior autologous SCT
2
[ "relapsed", "after", "prior", "autologous", "SCT" ]
[ 0, 0, 1, 1, 1 ]
NCT00980538
79:82:allergy_name
Previously demonstrated clinically significant allergy or hypersensitivity to ETR or to any of the excipients of ETR
2
[ "Previously", "demonstrated", "clinically", "significant", "allergy", "or", "hypersensitivity", "to", "ETR", "or", "to", "any", "of", "the", "excipients", "of", "ETR" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 4, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02727972
31:35:chronic_disease
Clinical diagnosis of current PTSD as per DSM-IV
2
[ "Clinical", "diagnosis", "of", "current", "PTSD", "as", "per", "DSM-IV" ]
[ 0, 0, 0, 0, 2, 0, 0, 0 ]
NCT02557321
24:29:chronic_disease,33:56:chronic_disease,58:82:chronic_disease,84:89:chronic_disease,91:107:chronic_disease,109:118:chronic_disease,120:133:chronic_disease,135:144:chronic_disease,149:181:chronic_disease
Clinically significant acute or unstable cardiovascular, cerebrovascular (stroke), renal, gastrointestinal, pulmonary, immunological, endocrine, or central nervous system disorders
2
[ "Clinically", "significant", "acute", "or", "unstable", "cardiovascular", ",", "cerebrovascular", "(", "stroke", ")", ",", "renal", ",", "gastrointestinal", ",", "pulmonary", ",", "immunological", ",", "endocrine", ",", "or", "central", "nervous", "system", "disor...
[ 0, 0, 2, 0, 2, 2, 0, 2, 2, 0, 0, 0, 2, 0, 2, 0, 2, 0, 2, 0, 2, 0, 0, 2, 2, 2, 2 ]
NCT03154580
1:17:chronic_disease
Major depression that is not substance-induced)
2
[ "Major", "depression", "that", "is", "not", "substance-induced", ")" ]
[ 2, 2, 0, 0, 0, 0, 0 ]
NCT02456857
7:14:treatment,20:31:treatment,33:54:treatment,59:69:treatment
Prior therapy with bevacizumab, liposomal doxorubicin, or everolimus
2
[ "Prior", "therapy", "with", "bevacizumab", ",", "liposomal", "doxorubicin", ",", "or", "everolimus" ]
[ 0, 1, 0, 1, 0, 1, 1, 0, 0, 1 ]
NCT02501096
9:35:cancer,81:210:treatment,234:245:treatment,276:297:treatment,307:316:treatment
For the renal cell carcinoma (RCC) cohort, participants must have progressed on treatment with an anti- programmed death receptor-1 /programmed death receptor-ligand 1 monoclonal antibody (anti-PD-1/PD-L1 mAb) administered either as monotherapy, or in combination with other checkpoint inhibitors or other therapies
2
[ "For", "the", "renal", "cell", "carcinoma", "(", "RCC", ")", "cohort", ",", "participants", "must", "have", "progressed", "on", "treatment", "with", "an", "anti-", "programmed", "death", "receptor-1", "/programmed", "death", "receptor-ligand", "1", "monoclonal", ...
[ 0, 0, 3, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 1 ]
NCT02514915
,,79:106:treatment
Patients with a documented symptomatic lesion size smaller than 3cm requiring clinical surgical resection
2
[ "Patients", "with", "a", "documented", "symptomatic", "lesion", "size", "smaller", "than", "3cm", "requiring", "clinical", "surgical", "resection" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1 ]
NCT02135588
1:39:chronic_disease
Traumatic hemorrhagic pleural effusion
2
[ "Traumatic", "hemorrhagic", "pleural", "effusion" ]
[ 2, 2, 2, 2 ]
NCT03112863
21:33:treatment,
Those who have used isotretinoin in the last 6 months
2
[ "Those", "who", "have", "used", "isotretinoin", "in", "the", "last", "6", "months" ]
[ 0, 0, 0, 0, 1, 0, 0, 0, 0, 0 ]
NCT02498613
23:35:treatment,39:41:treatment,,79:91:treatment,
Patients who have had chemotherapy or RT within 3 weeks prior to start of the study agents, or those who have not recovered from adverse events due to agents administered more than 3 weeks earlier
2
[ "Patients", "who", "have", "had", "chemotherapy", "or", "RT", "within", "3", "weeks", "prior", "to", "start", "of", "the", "study", "agents", ",", "or", "those", "who", "have", "not", "recovered", "from", "adverse", "events", "due", "to", "agents", "admini...
[ 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02193191
45:64:chronic_disease,111:135:treatment
Patients must have confirmed and measurable Sickle Cell Disease, defined by SS or Sβ thalassemia confirmed by hemoglobin fractionation
2
[ "Patients", "must", "have", "confirmed", "and", "measurable", "Sickle", "Cell", "Disease", ",", "defined", "by", "SS", "or", "Sβ", "thalassemia", "confirmed", "by", "hemoglobin", "fractionation" ]
[ 0, 0, 0, 0, 0, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT02203695
25:38:treatment,40:60:treatment,65:88:treatment
Concurrent use of other antiandrogens, estrogen-like agents, or 5a-reductase inhibitors
2
[ "Concurrent", "use", "of", "other", "antiandrogens", ",", "estrogen-like", "agents", ",", "or", "5a-reductase", "inhibitors" ]
[ 0, 0, 0, 0, 1, 0, 1, 1, 0, 0, 1, 1 ]
NCT02342782
45:113:allergy_name
History of allergic reactions attributed to compounds of similar chemical or biologic composition to basiliximab
2
[ "History", "of", "allergic", "reactions", "attributed", "to", "compounds", "of", "similar", "chemical", "or", "biologic", "composition", "to", "basiliximab" ]
[ 0, 0, 0, 0, 0, 0, 4, 4, 4, 4, 4, 4, 4, 4, 4 ]
NCT02335242
17:20:treatment,53:75:cancer,,,161:171:treatment
Have a required MRI examination to confirm that the lymphatic malformation is present and is greater than 3 cm in diameter in order for the subjects to receive medication, which happens during the initial screening evaluation portion of the trial
2
[ "Have", "a", "required", "MRI", "examination", "to", "confirm", "that", "the", "lymphatic", "malformation", "is", "present", "and", "is", "greater", "than", "3", "cm", "in", "diameter", "in", "order", "for", "the", "subjects", "to", "receive", "medication", ...
[ 0, 0, 0, 1, 0, 0, 0, 0, 0, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02762773
15:63:chronic_disease
Patients with pre-gestational or gestational diabetes mellitus
2
[ "Patients", "with", "pre-gestational", "or", "gestational", "diabetes", "mellitus" ]
[ 0, 0, 2, 2, 2, 2, 2 ]
NCT01787409
15:30:cancer,83:112:cancer,117:133:cancer,137:158:cancer
patients with B cell lymphoma, unclassifiable, with features intermediate between diffuse large B cell lymphoma and Burkitt lymphoma or post-transplant DLBCL are also eligible
2
[ "patients", "with", "B", "cell", "lymphoma", ",", "unclassifiable", ",", "with", "features", "intermediate", "between", "diffuse", "large", "B", "cell", "lymphoma", "and", "Burkitt", "lymphoma", "or", "post-transplant", "DLBCL", "are", "also", "eligible" ]
[ 0, 0, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 3, 3, 3, 3, 3, 0, 3, 3, 0, 3, 3, 0, 0, 0 ]
NCT02392286
8:21:chronic_disease,37:46:chronic_disease,55:74:chronic_disease
severe liver disease (decompensated cirrhosis, active alcoholic hepatitis)
2
[ "severe", "liver", "disease", "(", "decompensated", "cirrhosis", ",", "active", "alcoholic", "hepatitis", ")" ]
[ 0, 2, 2, 0, 0, 2, 0, 0, 2, 2, 0 ]
NCT02207465
1:17:cancer
Nodal metastases beyond the field of resection Borderline resectable
2
[ "Nodal", "metastases", "beyond", "the", "field", "of", "resection", "Borderline", "resectable" ]
[ 3, 3, 0, 0, 0, 0, 0, 0, 0 ]
NCT02670044
15:43:cancer
Patients with acute promyelocytic leukemia (French-American-British [FAB] class M3 AML)
2
[ "Patients", "with", "acute", "promyelocytic", "leukemia", "(", "French-American-British", "[", "FAB", "]", "class", "M3", "AML", ")" ]
[ 0, 0, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02214667
1:26:chronic_disease
schizophreniform disorder
2
[ "schizophreniform", "disorder" ]
[ 2, 2 ]
NCT02900794
,,22:44:chronic_disease
age 18 or older with chronic rhinosinusitis as described by the guidelines published in the 2015 Clinical practice guideline (update)
2
[ "age", "18", "or", "older", "with", "chronic", "rhinosinusitis", "as", "described", "by", "the", "guidelines", "published", "in", "the", "2015", "Clinical", "practice", "guideline", "(", "update", ")" ]
[ 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02091999
26:78:cancer,86:107:cancer,109:121:cancer,123:129:cancer,134:141:cancer
Histologically confirmed Transitional Cell Carcinoma of the Urothelium (TCCU) (i.e., cancer of the bladder, renal pelvis, ureter, or urethra
2
[ "Histologically", "confirmed", "Transitional", "Cell", "Carcinoma", "of", "the", "Urothelium", "(", "TCCU", ")", "(", "i.e.", ",", "cancer", "of", "the", "bladder", ",", "renal", "pelvis", ",", "ureter", ",", "or", "urethra" ]
[ 0, 0, 3, 3, 3, 3, 3, 3, 3, 0, 0, 0, 0, 0, 3, 3, 3, 3, 0, 3, 3, 0, 3, 0, 0, 3 ]
NCT03152058
1:26:chronic_disease,
Type 1 or Type 2 diabetes antedating pregnancy
2
[ "Type", "1", "or", "Type", "2", "diabetes", "antedating", "pregnancy" ]
[ 2, 2, 2, 2, 2, 2, 0, 0 ]
NCT01622868
1:38:chronic_disease,61:80:chronic_disease,121:134:treatment
Chronic obstructive pulmonary disease exacerbation or other respiratory illness requiring hospitalization or precluding study therapy at the time of study entry
2
[ "Chronic", "obstructive", "pulmonary", "disease", "exacerbation", "or", "other", "respiratory", "illness", "requiring", "hospitalization", "or", "precluding", "study", "therapy", "at", "the", "time", "of", "study", "entry" ]
[ 2, 2, 2, 2, 0, 0, 0, 2, 2, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0 ]
NCT01897259
27:39:chronic_disease
conservative treatment of tennis elbow is recommended as standard of care treatment
2
[ "conservative", "treatment", "of", "tennis", "elbow", "is", "recommended", "as", "standard", "of", "care", "treatment" ]
[ 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0 ]
NCT03088033
1:32:treatment
treatment with intravenous (IV)
2
[ "treatment", "with", "intravenous", "(", "IV", ")" ]
[ 1, 1, 1, 1, 0, 0 ]
NCT02937402
1:13:treatment,,
Coagulopathy with platelets (Plt) < 10 k
2
[ "Coagulopathy", "with", "platelets", "(", "Plt", ")", "<", "10", "k" ]
[ 1, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02514070
33:37:allergy_name,39:48:allergy_name,52:83:allergy_name
Known sensitivity or allergy to fish, shellfish or omega-3 fatty acids supplements
2
[ "Known", "sensitivity", "or", "allergy", "to", "fish", ",", "shellfish", "or", "omega-3", "fatty", "acids", "supplements" ]
[ 0, 0, 0, 0, 0, 4, 0, 4, 0, 4, 4, 4, 4 ]
NCT02632422
1:29:chronic_disease
severe autonomic dysreflexia
2
[ "severe", "autonomic", "dysreflexia" ]
[ 2, 2, 2 ]
NCT01893554
14:24:treatment,14:34:treatment,,84:104:treatment
Has received salicylate (aspirin) or salicylate-containing products within 28 days prior to inoculation
2
[ "Has", "received", "salicylate", "(", "aspirin", ")", "or", "salicylate-containing", "products", "within", "28", "days", "prior", "to", "inoculation" ]
[ 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1 ]
NCT01964404
14:27:chronic_disease
Diagnosis of schizophrenia
2
[ "Diagnosis", "of", "schizophrenia" ]
[ 0, 0, 2 ]
NCT02706353
43:71:cancer,76:92:cancer,99:114:cancer
Histologically or cytologically confirmed malignant melanoma from skin, or mucosal melanoma (i.e. ocular melanoma subjects are not eligible)
2
[ "Histologically", "or", "cytologically", "confirmed", "malignant", "melanoma", "from", "skin", ",", "or", "mucosal", "melanoma", "(", "i.e", ".", "ocular", "melanoma", "subjects", "are", "not", "eligible", ")" ]
[ 0, 0, 0, 0, 3, 3, 3, 3, 0, 0, 3, 3, 0, 0, 0, 3, 3, 0, 0, 0, 0, 0 ]
NCT02389309
1:15:treatment,17:28:treatment,30:42:treatment,44:56:treatment,58:66:treatment
Chlorpromazine, haloperidol, mesoridazine, thioridazine, pimozide
2
[ "Chlorpromazine", ",", "haloperidol", ",", "mesoridazine", ",", "thioridazine", ",", "pimozide" ]
[ 1, 0, 1, 0, 1, 0, 1, 0, 1 ]
NCT01966367
92:123:treatment
Requirement for CD34+ stem cell selection for a second infusion of stem cells following an allogeneic stem cell transplant from a related or unrelated adult donor
2
[ "Requirement", "for", "CD34+", "stem", "cell", "selection", "for", "a", "second", "infusion", "of", "stem", "cells", "following", "an", "allogeneic", "stem", "cell", "transplant", "from", "a", "related", "or", "unrelated", "adult", "donor" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT01697371
1:15:cancer
CNS metastases
2
[ "CNS", "metastases" ]
[ 3, 3 ]
NCT01220583
9:29:treatment,
History/physical examination within 8 weeks prior to registration
2
[ "History/physical", "examination", "within", "8", "weeks", "prior", "to", "registration" ]
[ 1, 1, 0, 0, 0, 0, 0, 0 ]
NCT03040778
1:29:chronic_disease
extensive retinal hemorrhage
2
[ "extensive", "retinal", "hemorrhage" ]
[ 2, 2, 2 ]
NCT01861106
31:34:cancer,,
The majority of patients with MDS will have less than 5% blasts
2
[ "The", "majority", "of", "patients", "with", "MDS", "will", "have", "less", "than", "5", "%", "blasts" ]
[ 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0 ]
NCT01795573
1:4:chronic_disease,17:22:treatment,26:82:treatment,75:81:treatment
HIV negative by ELISA or reverse transcription polymerase chain reaction (RT-PCR) [if ELISA is positive and RT-PCR is negative, the ELISA is considered false positive]
2
[ "HIV", "negative", "by", "ELISA", "or", "reverse", "transcription", "polymerase", "chain", "reaction", "(", "RT-PCR", ")", "[", "if", "ELISA", "is", "positive", "and", "RT-PCR", "is", "negative", ",", "the", "ELISA", "is", "considered", "false", "positive", ...
[ 2, 0, 0, 1, 0, 1, 1, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03108950
8:23:chronic_disease
Active pressure ulcers
2
[ "Active", "pressure", "ulcers" ]
[ 0, 2, 2 ]
NCT02912572
41:60:cancer
first cohort (MSI/POLE cohort) includes endometrial cancers
2
[ "first", "cohort", "(", "MSI/POLE", "cohort", ")", "includes", "endometrial", "cancers" ]
[ 0, 0, 0, 0, 0, 0, 0, 3, 3 ]
NCT02167009
9:27:treatment
Refuses surgical treatment
2
[ "Refuses", "surgical", "treatment" ]
[ 0, 1, 1 ]
NCT00840047
,17:26:treatment,
More than 6 MET PET scans within the previous 12 months
2
[ "More", "than", "6", "MET", "PET", "scans", "within", "the", "previous", "12", "months" ]
[ 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0 ]
NCT02094794
1:24:treatment
Prior radiation therapy that would exclude the use of TMLI
2
[ "Prior", "radiation", "therapy", "that", "would", "exclude", "the", "use", "of", "TMLI" ]
[ 1, 1, 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT02159703
75:89:cancer
Presence of close (2 mm) or positive margins PNI on TORS resection of the primary cancer
2
[ "Presence", "of", "close", "(", "2", "mm", ")", "or", "positive", "margins", "PNI", "on", "TORS", "resection", "of", "the", "primary", "cancer" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3 ]
NCT02555280
1:14:chronic_disease
pars fracture
2
[ "pars", "fracture" ]
[ 2, 2 ]
NCT03017937
8:32:chronic_disease,
Recent penetrating brain trauma (within 6 months)
2
[ "Recent", "penetrating", "brain", "trauma", "(", "within", "6", "months", ")" ]
[ 0, 2, 2, 2, 0, 0, 0, 0, 0 ]
NCT01750567
24:39:chronic_disease
Patient with confirmed del11q mutation may be included if untreated
2
[ "Patient", "with", "confirmed", "del11q", "mutation", "may", "be", "included", "if", "untreated" ]
[ 0, 0, 0, 2, 2, 0, 0, 0, 0, 0 ]
NCT02947945
30:42:treatment,44:56:treatment,61:82:treatment,
Subjects who have received a methotrexate, azathioprine, or mycophenolate mofetil induction regimen may be included if on a stable dose for at least 4 weeks prior to visit 1
2
[ "Subjects", "who", "have", "received", "a", "methotrexate", ",", "azathioprine", ",", "or", "mycophenolate", "mofetil", "induction", "regimen", "may", "be", "included", "if", "on", "a", "stable", "dose", "for", "at", "least", "4", "weeks", "prior", "to", "vi...
[ 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02594111
1:13:treatment
cyclosporine
2
[ "cyclosporine" ]
[ 1 ]
NCT02402660
,148:177:treatment
At least one eye (called the primary study eye) must have at least one well-demarcated area of significantly reduced autofluorescence as imaged by fundus autofluorescence (FAF)
2
[ "At", "least", "one", "eye", "(", "called", "the", "primary", "study", "eye", ")", "must", "have", "at", "least", "one", "well-demarcated", "area", "of", "significantly", "reduced", "autofluorescence", "as", "imaged", "by", "fundus", "autofluorescence", "(", "...
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0 ]
NCT02468453
21:58:chronic_disease,60:76:chronic_disease,78:89:chronic_disease,99:117:chronic_disease,124:144:chronic_disease,146:151:chronic_disease
Subject has a known collagen (connective tissue) disorder, vascular disease, scleroderma or other autoimmune disease (i.e. rheumatoid arthritis, lupus)
2
[ "Subject", "has", "a", "known", "collagen", "(", "connective", "tissue", ")", "disorder", ",", "vascular", "disease", ",", "scleroderma", "or", "other", "autoimmune", "disease", "(", "i.e", ".", "rheumatoid", "arthritis", ",", "lupus", ")" ]
[ 0, 0, 0, 0, 2, 2, 2, 2, 0, 0, 0, 2, 2, 0, 2, 0, 0, 2, 2, 0, 0, 0, 2, 2, 0, 2, 0 ]
NCT01804634
15:37:treatment,43:55:treatment,59:80:treatment
Refractory to induction chemotherapy with COG ANBL0532 or standard chemotherapy
2
[ "Refractory", "to", "induction", "chemotherapy", "with", "COG", "ANBL0532", "or", "standard", "chemotherapy" ]
[ 0, 0, 1, 1, 0, 1, 1, 0, 1, 1 ]
NCT01389024
,,107:124:treatment
Room air oxygen saturation greater than or equal to 5% below the participant's baseline on the day of the MRI with sedation
2
[ "Room", "air", "oxygen", "saturation", "greater", "than", "or", "equal", "to", "5", "%", "below", "the", "participant", "'s", "baseline", "on", "the", "day", "of", "the", "MRI", "with", "sedation" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1 ]
NCT03054519
1:13:treatment,
gene therapy study so long as at least six months have passed since the final intervention administration
2
[ "gene", "therapy", "study", "so", "long", "as", "at", "least", "six", "months", "have", "passed", "since", "the", "final", "intervention", "administration" ]
[ 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02640638
1:24:chronic_disease
Pregestational diabetes
2
[ "Pregestational", "diabetes" ]
[ 2, 2 ]
NCT02122185
38:60:treatment
Patients who are receiving any other investigational agents
2
[ "Patients", "who", "are", "receiving", "any", "other", "investigational", "agents" ]
[ 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT02099240
67:98:treatment
Isolation of an organism from bone culture that is susceptible to intravenous and oral antibiotic
2
[ "Isolation", "of", "an", "organism", "from", "bone", "culture", "that", "is", "susceptible", "to", "intravenous", "and", "oral", "antibiotic" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1 ]
NCT01366612
19:30:chronic_disease,35:60:chronic_disease,75:84:treatment
Recovery from all hematologic and non-hematology toxicities from previous therapies
2
[ "Recovery", "from", "all", "hematologic", "and", "non-hematology", "toxicities", "from", "previous", "therapies" ]
[ 0, 0, 0, 2, 0, 2, 2, 0, 0, 1 ]
NCT02471833
1:14:chronic_disease
Heart failure
2
[ "Heart", "failure" ]
[ 2, 2 ]
NCT02567266
20:52:chronic_disease
Adolescents with a current substance abuse disorder as determined using the ADIS-5-C/P
2
[ "Adolescents", "with", "a", "current", "substance", "abuse", "disorder", "as", "determined", "using", "the", "ADIS-5-C/P" ]
[ 0, 0, 0, 2, 2, 2, 2, 0, 0, 0, 0, 0 ]
NCT02939183
34:78:treatment
Currently receiving treatment in another investigational device or drug study
2
[ "Currently", "receiving", "treatment", "in", "another", "investigational", "device", "or", "drug", "study" ]
[ 0, 0, 0, 0, 1, 1, 1, 1, 1, 1 ]
NCT02974686
4:61:treatment
On standard immunosuppression with tacrolimus and prednisone
2
[ "On", "standard", "immunosuppression", "with", "tacrolimus", "and", "prednisone" ]
[ 0, 1, 1, 1, 1, 1, 1 ]
NCT03129542
1:23:chronic_disease
ischemic bowel disease
2
[ "ischemic", "bowel", "disease" ]
[ 2, 2, 2 ]
NCT01905709
,33:36:chronic_disease
At least two episodes of severe CDI resulting in hospitalization and associated with significant morbidity
2
[ "At", "least", "two", "episodes", "of", "severe", "CDI", "resulting", "in", "hospitalization", "and", "associated", "with", "significant", "morbidity" ]
[ 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02195232
22:28:treatment,32:45:treatment,63:78:chronic_disease
Known intolerance of niacin or ascorbic acid (including known G6PD deficiency)
2
[ "Known", "intolerance", "of", "niacin", "or", "ascorbic", "acid", "(", "including", "known", "G6PD", "deficiency", ")" ]
[ 0, 0, 0, 1, 0, 1, 1, 0, 0, 0, 2, 2, 0 ]
NCT03033212
7:21:treatment,32:43:treatment,44:54:treatment
Prior spinal surgery excluding laminectomy/discectomy
2
[ "Prior", "spinal", "surgery", "excluding", "laminectomy/discectomy" ]
[ 0, 1, 1, 0, 1 ]
NCT02615249
41:61:treatment,63:72:treatment,76:82:treatment,
Participation in a clinical trial of an investigational drug, treatment or device during this study or 3 weeks prior to inclusion in this study
2
[ "Participation", "in", "a", "clinical", "trial", "of", "an", "investigational", "drug", ",", "treatment", "or", "device", "during", "this", "study", "or", "3", "weeks", "prior", "to", "inclusion", "in", "this", "study" ]
[ 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02931110
19:21:chronic_disease,,,,,,
For subjects with MM, measurable disease with serum monoclonal immunoglobulin protein (M-protein) ≥1 g/dL, or urine M-protein protein ≥200 mg/24 hours, or involved serum free light chain (SFLC) ≥10 mg/dL
2
[ "For", "subjects", "with", "MM", ",", "measurable", "disease", "with", "serum", "monoclonal", "immunoglobulin", "protein", "(", "M-protein", ")", "≥1", "g/dL", ",", "or", "urine", "M-protein", "protein", "≥200", "mg/24", "hours", ",", "or", "involved", "serum"...
[ 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02876302
79:90:treatment
Because no dosing or adverse event data are currently available on the use of ruxolitinib in participants
2
[ "Because", "no", "dosing", "or", "adverse", "event", "data", "are", "currently", "available", "on", "the", "use", "of", "ruxolitinib", "in", "participants" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0 ]
NCT01433965
,62:74:treatment
Lactating females must agree not to breast feed while taking lenalidomide
2
[ "Lactating", "females", "must", "agree", "not", "to", "breast", "feed", "while", "taking", "lenalidomide" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT01928576
24:49:treatment,69:97:treatment,90:97:treatment,104:137:treatment
subject who received a tyrosine kinase inhibitor after failure of a prior platinum-based therapy, that tyrosine kinase inhibitor therapy would count as an additional line of therapy
2
[ "subject", "who", "received", "a", "tyrosine", "kinase", "inhibitor", "after", "failure", "of", "a", "prior", "platinum-based", "therapy", ",", "that", "tyrosine", "kinase", "inhibitor", "therapy", "would", "count", "as", "an", "additional", "line", "of", "thera...
[ 0, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02509260
1:31:treatment
enterocutaneous fistula repair
2
[ "enterocutaneous", "fistula", "repair" ]
[ 1, 1, 1 ]
NCT02516969
13:31:cancer
Evidence of distant metastases on any staging or imaging modality
2
[ "Evidence", "of", "distant", "metastases", "on", "any", "staging", "or", "imaging", "modality" ]
[ 0, 0, 3, 3, 0, 0, 0, 0, 0, 0 ]
NCT02453373
1:25:chronic_disease,,
Ischemic cortical stroke with NIHSS > _5_
2
[ "Ischemic", "cortical", "stroke", "with", "NIHSS", ">", "_5_" ]
[ 2, 2, 2, 0, 0, 0, 0 ]
NCT02389309
1:11:treatment,13:20:treatment,22:31:treatment,33:43:treatment
Amiodarone, sotalol, ibutilide, dofetilide
2
[ "Amiodarone", ",", "sotalol", ",", "ibutilide", ",", "dofetilide" ]
[ 1, 0, 1, 0, 1, 0, 1 ]
NCT02876510
1:29:chronic_disease
gastrointestinal obstruction
2
[ "gastrointestinal", "obstruction" ]
[ 2, 2 ]